Effects of S-8510, a novel benzodiazepine receptor partial inverse agonist, on basal forebrain lesioning-induced dysfunction in rats

European Journal of Pharmacology
K AbeK Yoshimura

Abstract

We investigated the effects of a novel benzodiazepine partial inverse agonist, S-8510 (2-(3-isoxazolyl)-3,6,7,9-tetrahydroimidazo [4,5-d] pyrano [4,3-b] pyridine monophosphate monohydrate), on the impairment of spatial memory, decreased high-affinity choline uptake and acetylcholine release in basal forebrain-lesioned rats. S-8510 (3 and 5 mg/kg, p.o. 30 min before each training session) significantly ameliorated the basal forebrain-lesion-induced impairment of spatial memory in water maze task. In vivo brain microdialysis studies showed that systemic administration of S-8510 at 3 and 10 mg/kg significantly increased the release of acetylcholine in the front-parietal cortex in basal forebrain-lesioned rats. Further, repeated administration of S-8510 (3 and 10 mg kg(-1) day(-1) for 5 days) reversed the decrease in cortical high-affinity choline uptake induced by basal forebrain lesion. Thus, S-8510 improved the spatial memory impairment induced by lesion of the basal forebrain in rats. In addition, it increased acetylcholine release and high-affinity choline uptake from the cortex, a region closely associated with memory, in basal forebrain-lesioned rats. These results indicate that S-8510 has cognition enhancing and cholinergic...Continue Reading

References

Sep 1, 1992·British Journal of Pharmacology·J A MillerJ M Kane
Nov 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J D BuxbaumP Greengard
Jul 1, 1991·Trends in Pharmacological Sciences·I Izquierdo, J H Medina
Jun 1, 1991·Trends in Neurosciences·K S Kosik
Nov 1, 1991·Behavioral and Neural Biology·J D BrioniI Izquierdo
Oct 1, 1991·Trends in Pharmacological Sciences·J Hardy, D Allsop
Jan 1, 1988·Trends in Neurosciences·M SarterD N Stephens
Jan 1, 1989·Psychopharmacology·H S Koelega
Jul 1, 1988·Pharmacology, Biochemistry, and Behavior·M Sarter, H H Schneider
Jan 1, 1985·Neuroscience and Biobehavioral Reviews·M H Thiébot
Jan 1, 1986·Psychopharmacology·S E File, S Pellow
Jun 30, 1987·Brain Research·A M PalmerJ S Snowden
Sep 1, 1987·Brain Research Bulletin·L H JensenE N Petersen
Mar 15, 1984·Biochemical Pharmacology·C BraestrupL H Jensen
Feb 1, 1983·Journal of Neurochemistry·N R SimsA N Davison
Apr 15, 1994·Journal of Neuroscience Research·D K LahiriM R Farlow
Nov 1, 1996·Progress in Neuro-psychopharmacology & Biological Psychiatry·K KawasakiM Yasui
Feb 26, 1997·European Journal of Pharmacology·K AbeK Yoshimura
Jan 1, 1985·Neurochemistry International·M N Rossor

❮ Previous
Next ❯

Citations

Apr 6, 2004·Psychopharmacology·Daniel BeracocheaChristophe Pierard
Aug 30, 2001·European Journal of Pharmacology·T M DeLoreyG H Loew
Aug 23, 2001·Brain Research. Brain Research Reviews·R D'Hooge, P P De Deyn
Apr 3, 2001·Expert Opinion on Investigational Drugs·M Emre, N Qizilbash
Jul 6, 2005·Pharmacology & Therapeutics·Esa R Korpi, Saku T Sinkkonen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.